Focus on Cdc42 in Breast Cancer: New Insights, Target Therapy Development and Non-Coding RNAs
Breast cancer is the most common malignant tumors in females. Although the conventional treatment has demonstrated a certain effect, some limitations still exist. The Rho guanosine triphosphatase (GTPase) Cdc42 (Cell division control protein 42 homolog) is often upregulated by some cell surface rece...
Main Authors: | Yu Zhang, Jun Li, Xing-Ning Lai, Xue-Qiao Jiao, Jun-Ping Xiong, Li-Xia Xiong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/2/146 |
Similar Items
-
Regulating Cdc42 and Its Signaling Pathways in Cancer: Small Molecules and MicroRNA as New Treatment Candidates
by: Xing-Hua Xiao, et al.
Published: (2018-03-01) -
Identification of amino acids involved in Cdc42-calmodulin interaction and regulation of Cdc42 activation
by: Grewal, Navneet
Published: (2015) -
Overexpression of CDC42SE1 in A431 Cells Reduced Cell Proliferation by Inhibiting the Akt Pathway
by: Pazhanichamy Kalailingam, et al.
Published: (2019-02-01) -
Cdc42 Effector Protein 3 Interacts With Cdc42 in Regulating Xenopus Somite Segmentation
by: Mary Kho, et al.
Published: (2019-05-01) -
Cdc42: A Novel Regulator of Insulin Secretion and Diabetes-Associated Diseases
by: Qi-Yuan Huang, et al.
Published: (2019-01-01)